Spagnol, G.; Bigardi, S.; Zorzi, M.; Morotti, M.; Carollo, M.; Bruni, G.M.; De Tommasi, O.; Tamagnini, M.; Xhindoli, L.; Noventa, M.;
et al. Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer. J. Clin. Med. 2024, 13, 6915.
https://doi.org/10.3390/jcm13226915
AMA Style
Spagnol G, Bigardi S, Zorzi M, Morotti M, Carollo M, Bruni GM, De Tommasi O, Tamagnini M, Xhindoli L, Noventa M,
et al. Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer. Journal of Clinical Medicine. 2024; 13(22):6915.
https://doi.org/10.3390/jcm13226915
Chicago/Turabian Style
Spagnol, Giulia, Sofia Bigardi, Michela Zorzi, Matteo Morotti, Massimo Carollo, Giulia Micol Bruni, Orazio De Tommasi, Matteo Tamagnini, Livia Xhindoli, Marco Noventa,
and et al. 2024. "Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer" Journal of Clinical Medicine 13, no. 22: 6915.
https://doi.org/10.3390/jcm13226915
APA Style
Spagnol, G., Bigardi, S., Zorzi, M., Morotti, M., Carollo, M., Bruni, G. M., De Tommasi, O., Tamagnini, M., Xhindoli, L., Noventa, M., Tozzi, R., Saccardi, C., & Marchetti, M.
(2024). Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer. Journal of Clinical Medicine, 13(22), 6915.
https://doi.org/10.3390/jcm13226915